BioAtla (BCAB) News Today $1.74 -0.11 (-5.95%) (As of 09/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 4 at 10:58 AM | finance.yahoo.comCompanies Like BioAtla (NASDAQ:BCAB) Could Be Quite RiskyAugust 31, 2024 | marketbeat.comShort Interest in BioAtla, Inc. (NASDAQ:BCAB) Rises By 18.8%BioAtla, Inc. (NASDAQ:BCAB - Get Free Report) saw a significant growth in short interest in the month of August. As of August 15th, there was short interest totalling 4,750,000 shares, a growth of 18.8% from the July 31st total of 4,000,000 shares. Based on an average daily volume of 955,100 shares, the days-to-cover ratio is currently 5.0 days.August 28, 2024 | finance.yahoo.comBioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 21, 2024 | markets.businessinsider.comBuy Rating for BioAtla: Promising Pipeline and Strategic Partnerships Fuel Optimistic OutlookAugust 15, 2024 | msn.comMichael Burry increases Alibaba stake, halves stock portfolioAugust 15, 2024 | msn.comMichael Burry of ‘The Big Short' increases Alibaba stake, halves stock portfolioAugust 13, 2024 | markets.businessinsider.comReni Benjamin’s Buy Rating for BioAtla: Strong Pipeline and Financial Health Signal Upside PotentialAugust 11, 2024 | seekingalpha.comBioAtla, Inc. (BCAB) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | marketbeat.comBioAtla (NASDAQ:BCAB) Issues Earnings Results, Beats Expectations By $0.01 EPSBioAtla (NASDAQ:BCAB - Get Free Report) released its earnings results on Thursday. The company reported ($0.44) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.45) by $0.01. During the same quarter last year, the company posted ($0.75) EPS.August 9, 2024 | markets.businessinsider.comBioatla Reports Second Quarter 2024 Financial Results and Highlights Recent ProgressAugust 9, 2024 | msn.comBCAB Stock Earnings: BioAtla Meets EPS for Q2 2024August 7, 2024 | sg.finance.yahoo.comBioAtla, Inc. (BCAB) stock price, news, quote & history – Yahoo FinanceAugust 2, 2024 | marketbeat.comBioAtla (BCAB) Set to Announce Quarterly Earnings on ThursdayBioAtla (NASDAQ:BCAB) will be releasing earnings after the market closes on Thursday, August 8, Zacks reports.July 29, 2024 | markets.businessinsider.comBioAtla (BCAB) Receives a Buy from J.P. MorganJuly 27, 2024 | marketbeat.comBioAtla, Inc. (NASDAQ:BCAB) Short Interest Down 24.2% in JulyBioAtla, Inc. (NASDAQ:BCAB - Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 15th, there was short interest totalling 3,980,000 shares, a drop of 24.2% from the June 30th total of 5,250,000 shares. Based on an average daily volume of 880,600 shares, the short-interest ratio is currently 4.5 days.July 25, 2024 | globenewswire.comBioAtla Highlighted Clinical Program and Pipeline Updates at Virtual R&D DayJuly 23, 2024 | markets.businessinsider.comBioAtla Says Its Drug Ozuriftamab Vedotin To Treat SCCHN Got Fast Track DesignationJuly 9, 2024 | 247wallst.com3 Penny Stocks With 735% Average Upside, According to Wall StreetJuly 9, 2024 | marketbeat.comBioAtla (NASDAQ:BCAB) Trading Down 3.8%BioAtla (NASDAQ:BCAB) Trading Down 3.8%May 29, 2024 | globenewswire.comBioAtla to Participate in the Jefferies Global Healthcare ConferenceMay 23, 2024 | globenewswire.comBioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upcoming 2024 American Society of Clinical Oncology (ASCO) Annual MeetingMay 23, 2024 | markets.businessinsider.comBuy Rating for BioAtla: Promising Clinical Data and Strong Financial Position Signal Upside PotentialMay 23, 2024 | marketbeat.comBioAtla (NASDAQ:BCAB) Price Target Lowered to $5.00 at JMP SecuritiesJMP Securities cut their target price on shares of BioAtla from $12.00 to $5.00 and set a "market outperform" rating on the stock in a research report on Thursday.May 23, 2024 | finance.yahoo.comInstitutional owners may consider drastic measures as BioAtla, Inc.'s (NASDAQ:BCAB) recent US$35m drop adds to long-term lossesMay 17, 2024 | marketbeat.comHC Wainwright Analysts Increase Earnings Estimates for BioAtla, Inc. (NASDAQ:BCAB)BioAtla, Inc. (NASDAQ:BCAB - Free Report) - HC Wainwright boosted their Q2 2024 earnings per share (EPS) estimates for BioAtla in a note issued to investors on Wednesday, May 15th. HC Wainwright analyst A. He now forecasts that the company will post earnings of ($0.51) per share for the quarter,May 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioAtla on Strong Clinical Data and Strategic Pipeline ProgressMay 15, 2024 | marketbeat.comBioAtla (NASDAQ:BCAB) Earns Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $7.00 target price on shares of BioAtla in a research report on Wednesday.May 15, 2024 | msn.comBioAtla, Inc. (NASDAQ:BCAB) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comBioAtla Inc (BCAB) (Q1 2024) Earnings Call Transcript Highlights: Strategic Adjustments and ...May 14, 2024 | investorplace.comBCAB Stock Earnings: BioAtla Beats EPS for Q1 2024May 14, 2024 | globenewswire.comBioAtla Reports First Quarter 2024 Financial Results and Highlights Recent ProgressMay 8, 2024 | globenewswire.comBioAtla to Participate in the Citizens JMP Life Sciences ConferenceMay 7, 2024 | finance.yahoo.comBioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024May 6, 2024 | markets.businessinsider.comBioAtla Says FDA Clears IND Application For BA3361 For The Treatment Of Multiple TumorsMay 6, 2024 | globenewswire.comBioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple TumorsMay 3, 2024 | nasdaq.comBioAtla, Inc. Common Stock (BCAB)May 2, 2024 | seekingalpha.comBioAtla: A Buried ADC Concern Gets Some New Life In 2024April 30, 2024 | finance.yahoo.comBioAtla, Inc. (BCAB)April 24, 2024 | globenewswire.comBioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingApril 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioAtla on Strong Clinical Pipeline and Financial StabilityApril 5, 2024 | seekingalpha.comGRIN, WOOF and MRNS are among after hour moversMarch 29, 2024 | marketbeat.comBioAtla, Inc. Expected to Earn FY2028 Earnings of ($0.09) Per Share (NASDAQ:BCAB)BioAtla, Inc. (NASDAQ:BCAB - Free Report) - Stock analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for shares of BioAtla in a report released on Wednesday, March 27th. HC Wainwright analyst A. He expects that the company will post earnings per share of ($0.09) forMarch 28, 2024 | marketbeat.comBioAtla's (BCAB) "Market Outperform" Rating Reiterated at JMP SecuritiesJMP Securities reissued a "market outperform" rating and set a $12.00 price objective on shares of BioAtla in a research note on Thursday.March 27, 2024 | markets.businessinsider.comOptimistic Outlook for BioAtla’s Pipeline Progression and Potential PartnershipsMarch 27, 2024 | finance.yahoo.comBioAtla, Inc. (NASDAQ:BCAB) Q4 2023 Earnings Call TranscriptMarch 26, 2024 | benzinga.comBioAtla: Q4 Earnings InsightsMarch 26, 2024 | finance.yahoo.comBioAtla Inc (BCAB) Posts Q4 and Full Year 2023 Financial ResultsMarch 26, 2024 | globenewswire.comBioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent ProgressMarch 25, 2024 | benzinga.comPreview: BioAtla's EarningsMarch 20, 2024 | marketbeat.comBioAtla (BCAB) Set to Announce Earnings on TuesdayBioAtla (NASDAQ:BCAB) will be releasing earnings after the market closes on Tuesday, March 26, Zacks reports. Get BioAtla News Delivered to You Automatically Sign up to receive the latest news and ratings for BCAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s Capital Gains Tax to Devastate Savings! (Ad)Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security. >> Get Your FREE Wealth Protection Guide << BCAB Media Mentions By Week BCAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCAB News Sentiment▼1.330.55▲Average Medical News Sentiment BCAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCAB Articles This Week▼21▲BCAB Articles Average Week Get BioAtla News Delivered to You Automatically Sign up to receive the latest news and ratings for BCAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACB News KMDA News JSPR News URGN News AKBA News AVIR News GLTO News ZVRA News ACIU News ADAP News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCAB) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAtla, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioAtla With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
